Thera Tablets with Beta Carotene Dietary Supplement

The Harvard Drug Group, LLC recalled Thera Tablets with Beta Carotene Dietary Supplement in a Class III action, the FDA tier used when a product is unlikely to cause adverse health effects, typically for labeling or minor regulatory issues on Dec 31, 2014.

The FDA-published reason for this recall is: "The firm received a complaint that the blister packets were missing labeling information on 12/16/2014, the firm investigated the labeling complaint and found that six 2 x 5 blister cards inside a carton was missing some or all of the product information on the back of the blister card."

Distribution was broad: the FDA record describes it as "Domestic: AL, AZ, CA, CO, CT, FL, GA, IL, KY, MA, MI, MO, MS, NC, NE NJ, NY, OH, OR, PA, TN, TX, UT, VA, WA, WI, WV. Foreign: None Foreign:," which places this among the wider-reach recalls on the site. Consumers across the affected area should check product on hand. The recalling firm is based in Livonia, MI. The recall covers 5,700 unit doses 10 x 10 cartons of product. The FDA has Terminated this recall (first reported Feb 4, 2015), its final lifecycle state, indicating the agency considers the corrective action resolved. The historical record remains useful for tracking a brand's recall pattern over time.